share_log
Reuters ·  Mar 26 13:07
Sonnet Biotherapeutics Holdings : Safety Review Committee Found No Unexpected Toxicities in Early Dosing of Son-1010 in First 7 Patients at Mtd
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 229

Recommended

Write a comment